EU may allow drug marketing to patients

Article Abstract:

This article discusses proposals of the European Commission regarding the marketing of drugs in the European Union. Officials are responding to the demands by groups representing patients with such diseases as AIDS diabetes and asthma that more consumer information be made available.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, European Union, International economic relations, Drugs, Statistical Data Included, European Union. European Commission

---

Sanofi weight-loss drug gains support in Europe

Article Abstract:

Rimonabant the anti-obesity drug by Sanofi-Aventis S.A. of France has been approved for market by European regulators. The drug is being marketed under the trade names Acomplia and Zimutti. The United States Food and Drug Administration has postponed an approval decision.

Europe, Product development, Legal issues & crime, Government regulation (cont), France, Government regulation, Pharmaceutical preparations, Legal/Government Regulation, Weight reducing preparations, Anti-obesity agents, Acomplia (Medication), SNY, Sanofi-Aventis S.A., Zimutti (Medication)

---

Similar abstracts:

• Abstracts: Marketing to the masses. Shaking up Coke in Japan. Designing a new China
• Abstracts: Market orientation and business performance: some European evidence. The market orientation-performance link: the role of service reliability
• Abstracts: sweden could delay euro entry. Swedish minister's murder puts euro vote in turmoil
• Abstracts: International marketing in Southeast Asia: Retailing trends and opportunities in China. International marketing and the Asia-Pacific Region: developments, opportunities, and research issues
• Abstracts: Israel unilaterally may set new border: Sharon would separate, leaving Palestinians less if road map is abandoned

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.